CytoMed Therapeutics Limited Interest Received Classified As Investing Activities
CytoMed Therapeutics Limited (GDTC) reported Interest Received Classified As Investing Activities of SGD 162.18 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2026-03-31
SGD
| Period end | Interest Received Classified As Investing Activities 12 month |
|---|---|
| 2025-12-31 | 162.18K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 465.57K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 98.37K SGD 20-F · filed 2026-03-31 |
USD
| Period end | Interest Received Classified As Investing Activities 12 month |
|---|---|
| 2025-12-31 | $126.12K 20-F · filed 2026-03-31 |
| 2024-12-31 | $340.77K 20-F · filed 2025-04-28 |